Skip to content

4Accepted Mar 2, 9:26 PM ET

Birznieks Gunther 4

VNDAVanda Pharmaceuticals Inc.

sec.gov(opens the filing on sec.gov)View full filing

Accepted (ET)

9:26 PM

Mar 2, 2022

Filed

Mar 2, 2022

Documents

1

Size

11.8 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.